Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients

Diabetes, Obesity and Metabolism

Volumn 12, Issue 8, 2010, Pages 731-733

  Rickels, M R ^a   Naji, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Glucagon; Glucagon like peptide 1; Insulin

Indexed keywords

ARGININE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RELEASE; LETTER; MALE; PANCREAS TRANSPLANTATION; STATISTICAL SIGNIFICANCE;

EID: 77958087153     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01208.x     Document Type: Letter

References (10)

1. Rickels MR, Mueller R, Markman JF, Naji A. Effect of GLP-1 on betaand alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab 2009; 94: 181-189.
2. Paty BW, Lanz K, Kendall DM, Sutherland DER, Robertson RP. Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 2001; 72: 1103-1107.
3. Nauck MA, Heimesaat MM, Behle K et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 2002; 87: 1239-1246.
4. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984; 74: 2296-2299.
5. Unger RH. Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes 1971; 20: 834-838.
6. Gebhard B, Holst JJ, Biegelmayer C, Miholic J. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 2001; 46: 1915-1923.
7. Goldfine AB, Mun EC, Devine E et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92: 4678-4685.
8. Todd JF, Stanley SA, Roufosse CA et al. A tumour that secretes glucagonlike peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet 2003; 361: 228-230.
9. Froud T, Faradji RN, Pileggi A et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, andmetabolic effects. Transplantation 2008; 86: 36-45.
10. Toft-Nielsen M, Madsbad S, Holst JJ. Exaggerated secretion of glucagonlike peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 1998; 41: 1180-1186.